Elan will sell the rights to its drug for multiple sclerosis to partnering company Biogen Idec for $3.25 billion plus royalties, the Irish drug maker said.
Israeli drug maker Taro Pharmaceutical Industries and Indian drug maker Sun Pharmaceutical Industries have terminated their merger agreement, the companies said in a joint statement Friday.
Reporting on the third quarter ended Dec. 31, Prestige Brands' CEO Matthew Mannelly told analysts he is "cautiously optimistic" regarding cough-cold reorders given the high consumption levels at retail in late December through January.
Cardinal Health posted $25.2 billion in revenue for its 2013 second quarter, down 7%. The company's non-GAAP diluted earnings per share was up 15% to $0.93.
U.K. grocer Tesco is attempting to reassure shoppers that its United States-based Fresh & Easy supermarkets are not closing after announcing in December plans to exit the U.S. market, Bloomberg News reported Friday.
Eli Lilly and Company reported that its fourth quarter revenue for the period ended Dec. 31 declined 1% to $6 billion because of its Zyprexa patent expiration. Full-year 2012 revenue declined 7% to $22.6 billion.
Johnson & Johnson is shopping its women's health unit, according to a report Friday in The Wall Street Journal, which suggested that the business no longer coincided with J&J's "growth priorities."
Kroger on Friday declared a quarterly dividend of 15¢ per share to be paid on March 1, 2013, to shareholders of record as of the close of business on Feb. 15, 2013.
Skin care products, including facial moisturizers and facial anti-aging products, experienced an uptick in sales, and the growth is expected to continue going forward as baby boomers help fuel sales and shoppers indulge in small luxuries.